[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335686-105":59,"doc-detail-335686-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","case-report-microsatellite-instability-high-pancreas-adenosquamous-carcinoma-with-postoperative-liver-metastasis-recurrence-treated-with-multimodality-therapy-achieving-complete-pathological-response","Case report - Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response","","Pancreatic adenosquamous carcinoma is a rare pancreatic cancer subtype with no consensus for postoperative liver metastasis recurrence management. A 48-year-old man underwent radical surgery and was pathologically diagnosed with microsatellite instability-high (MSI-H) pancreatic adenosquamous carcinoma. After recurrence of liver metastases following single-agent gemcitabine adjuvant chemotherapy, treatment combined transarterial chemoembolization using oxaliplatin, fluorouracil, and epirubicin, then six cycles of gemcitabine plus nab-paclitaxel together with sintilimab and bevacizumab. Complete pathological regression was achieved, and the patient reached 24-month survival under ongoing monitoring. The case highlights potential benefit of multimodality therapy for MSI-H PASC recurrence.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/case-report-microsatellite-instability-high-pancreas-adenosquamous-carcinoma-with-postoperative-liver-metastasis-recurrence-treated-with-multimodality-therapy-achieving-complete-pathological-response/335686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/case-report-microsatellite-instability-high-pancreas-adenosquamous-carcinoma-with-postoperative-liver-metastasis-recurrence-treated-with-multimodality-therapy-achieving-complete-pathological-response/335686.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What diagnosis was confirmed in the reported patient?","Question",{"text":113,"@type":114},"The patient was diagnosed with microsatellite instability-high (MSI-H) pancreatic adenosquamous carcinoma (PASC) after radical surgery.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the postoperative liver metastasis recurrence treated?",{"text":118,"@type":114},"The recurrence was managed with TACE using oxaliplatin, fluorouracil, and epirubicin, followed by six cycles of gemcitabine plus nab-paclitaxel with sintilimab and bevacizumab.",{"name":120,"@type":111,"acceptedAnswer":121},"What was the treatment outcome and follow-up status?",{"text":122,"@type":114},"Complete pathological regression of the liver metastasis was achieved, and the patient reached 24-month survival while continuing monitoring at the reporting center.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335686,1790098736,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Case Report  \nPUBLISHED 12 December 2024 DOI 10.3389/fimmu.2024.1456343  \nOPEN ACCESS  \nEDITED BY  \nPierosandro Tagliaferri,  \nMagna Græcia University, Italy  \nREVIEWED BY  \nShuai Ren,  \nAfﬁliated Hospital of Nanjing University of Chinese Medicine, China  \nGiulio Caridà,  \nMagna Græcia University of Catanzaro, Italy  \n*CORRESPONDENCE  \nPengfei Zheng  \n [mxzhengpengfei@163.com](mxzhengpengfei@163.com)  \nRECEIVED 28 June 2024  \nACCEPTED 26 November 2024  \nPUBLISHED 12 December 2024  \nCITATION  \nLiu Q, Li R, Zhu W and Zheng P (2024) Case report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response.  \nFront. Immunol. 15:1456343 .  \ndoi: 10.3389/fimmu.2024.1456343  \nCOPYRIGHT  \n© 2024 Liu, Li, Zhu and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCase report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response  \nQinghua Liu 1, Ruoyun Li 1, Wei Zhu 2 and Pengfei Zheng 1*  \n1 Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China, 2 Department of Pathology, Lanzhou University Second Hospital, Lanzhou, China  \nPancreatic adenosquamous carcinoma (PASC) is a rare subtype of pancreatic cancer (PC), with no established consensus on the optimal treatment for postoperative liver metastasis recurrence. We report a case of a 48-year-old male patient who underwent radical surgery and was pathologically diagnosed with microsatellite instability-high (MSI-H) PASC. The patient experienced liver metastasis recurrence following single-agent gemcitabine adjuvant chemotherapy. After one session of transarterial chemoembolization (TACE) with oxaliplatin, ﬂuorouracil, and epirubicin, followed by six cycles of adjuvant chemotherapy with gemcitabine and nabpaclitaxel combined with sintilimab immunotherapy and bevacizumab targeted therapy, complete pathological regression of the liver metastasis was achieved. The patient has now reached a 24-month survival period and continues to be monitored at our center. This case illustrates the promise of the proposed treatment regimen, highlighting the signiﬁcant potential of multimodality strategies in managing metastatic recurrence of MSI-H PASC.  \nKEYWORDS  \npancreatic adenosquamous carcinoma, microsatellite instability-high, chemotherapy immunotherapy, targeted therapy, recurrence, metastasis  \nIntroduction  \nPancreatic cancer (PC) is one of the most malignant types of cancer, with a 5-year survival rate below 13% and an increasing incidence rate (1) . PC consists of various histological types with varying degrees of differentiation, among which pancreatic adenosquamous carcinoma (PASC) is a rare variant, accounting for 1%-4% of PC  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \ncases (2) . Pathologically, PASC is deﬁned as a mixed tumor originating from the pancreatic duct epithelium, comprising both ductal and squamous differentiation, with at least 30% of the tumor being of the squamous component (3). Because of its unique clinical and histopathological characteristics, PASC exhibits higher malignancy, shorter survival, and a worse prognosis compared to other types of PC (4) . Surgical resection is the preferred treatment for PASC, but postoperative metastasis and recurrence frequently occur, signiﬁcantly affecting the patient prognosis (5) . Therefore, the development of effective treatme","cbCaigxuUr9gGEVo","https://ap.wps.com/l/cbCaigxuUr9gGEVo","pdf",6105516,"English","# Introduction\n## Pancreatic adenosquamous carcinoma and clinical challenge\n## Microsatellite instability as a biomarker\n## Current treatment landscape for advanced or recurrent pancreatic cancer\n# Case description and treatment course\n## Recurrence after adjuvant chemotherapy\n## TACE and subsequent multimodality systemic therapy\n## Outcome and follow-up","[{\"question\":\"What diagnosis was confirmed in the reported patient?\",\"answer\":\"The patient was diagnosed with microsatellite instability-high (MSI-H) pancreatic adenosquamous carcinoma (PASC) after radical surgery.\"},{\"question\":\"How was the postoperative liver metastasis recurrence treated?\",\"answer\":\"The recurrence was managed with TACE using oxaliplatin, fluorouracil, and epirubicin, followed by six cycles of gemcitabine plus nab-paclitaxel with sintilimab and bevacizumab.\"},{\"question\":\"What was the treatment outcome and follow-up status?\",\"answer\":\"Complete pathological regression of the liver metastasis was achieved, and the patient reached 24-month survival while continuing monitoring at the reporting center.\"}]","Case report - Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response | PDF",1790011941,18]